Mingxia Ding

1.1k total citations
51 papers, 773 citations indexed

About

Mingxia Ding is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Mingxia Ding has authored 51 papers receiving a total of 773 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 16 papers in Surgery and 15 papers in Cancer Research. Recurrent topics in Mingxia Ding's work include Bladder and Urothelial Cancer Treatments (12 papers), Ferroptosis and cancer prognosis (7 papers) and Epigenetics and DNA Methylation (7 papers). Mingxia Ding is often cited by papers focused on Bladder and Urothelial Cancer Treatments (12 papers), Ferroptosis and cancer prognosis (7 papers) and Epigenetics and DNA Methylation (7 papers). Mingxia Ding collaborates with scholars based in China, United States and Japan. Mingxia Ding's co-authors include Jiansong Wang, Ruping Yan, Hongbo Qi, Xuemei Zhang, Guoqing Liu, Hui Zhan, Hongkui Deng, Yuanyi Zheng, Hua Zhang and Xiaoqiu Xiao and has published in prestigious journals such as Journal of Clinical Oncology, Biomaterials and Cancer Research.

In The Last Decade

Mingxia Ding

44 papers receiving 767 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxia Ding China 15 461 173 138 113 88 51 773
Agnieszka Zimna Poland 9 341 0.7× 186 1.1× 114 0.8× 100 0.9× 74 0.8× 24 709
Simi Chacko Canada 15 452 1.0× 234 1.4× 193 1.4× 51 0.5× 37 0.4× 22 814
Zhendong Yu China 17 638 1.4× 292 1.7× 134 1.0× 86 0.8× 132 1.5× 47 1.1k
Rui He China 17 455 1.0× 155 0.9× 103 0.7× 61 0.5× 174 2.0× 85 929
Jianfeng Zhou China 16 278 0.6× 185 1.1× 155 1.1× 84 0.7× 195 2.2× 55 716
Ningning He China 19 534 1.2× 223 1.3× 138 1.0× 155 1.4× 189 2.1× 64 1.1k
Jin Kyeoung Kim South Korea 16 503 1.1× 272 1.6× 127 0.9× 53 0.5× 62 0.7× 36 777
Owen Tang Australia 14 304 0.7× 98 0.6× 104 0.8× 75 0.7× 48 0.5× 29 646

Countries citing papers authored by Mingxia Ding

Since Specialization
Citations

This map shows the geographic impact of Mingxia Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxia Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxia Ding more than expected).

Fields of papers citing papers by Mingxia Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxia Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxia Ding. The network helps show where Mingxia Ding may publish in the future.

Co-authorship network of co-authors of Mingxia Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxia Ding. A scholar is included among the top collaborators of Mingxia Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxia Ding. Mingxia Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Junhao, et al.. (2025). Roles and therapeutic potential of the SLC family in prostate cancer—literature review. BMC Urology. 25(1). 32–32. 1 indexed citations
2.
Li, Zhenkun, Wenhui Zhang, Ying Liang, et al.. (2025). Deciphering the tumor-suppressive role of RBMS3 in lung adenocarcinoma through genomic insights into prognosis and mechanisms. Scientific Reports. 15(1). 10722–10722.
3.
Fu, Shihui, Joseph Wu, Yiping Huang, et al.. (2025). Migrasomes, critical players in intercellular communication. Cancer Cell International. 25(1). 113–113. 2 indexed citations
4.
Chen, Gong, et al.. (2025). Potential of APOBEC3B as a therapeutic target and its role in bladder cancer onset and progression. European journal of medical research. 30(1). 740–740.
5.
6.
Chen, Xiaorong, et al.. (2024). HES4 is a potential biomarker for bladder cancer: a Mendelian randomization study. Journal of Cancer. 15(6). 1624–1641. 2 indexed citations
8.
Chen, Zhenjie, Shi Fu, Haifeng Wang, et al.. (2022). Hsa_circ_0102485 inhibits the growth of cancer cells by regulating the miR-188–3p/ARID5B/AR axis in prostate carcinoma. Pathology - Research and Practice. 237. 154052–154052. 1 indexed citations
9.
Xiong, Qiuxia, Baiyang Liu, Mingxia Ding, et al.. (2020). Hypoxia and cancer related pathology. Cancer Letters. 486. 1–7. 54 indexed citations
10.
Zhang, Jiashuo, et al.. (2020). Genetic polymorphism of 24 Y-STR loci in Altay Hui and Kazakh populations from northwest China. Legal Medicine. 47. 101760–101760. 6 indexed citations
11.
Ding, Mingxia, Weihong Shen, & Yifeng Hu. (2017). The Role of miR-539 in the Anterior Cingulate Cortex in Chronic Neuropathic Pain. Pain Medicine. 18(12). 2433–2442. 16 indexed citations
12.
Wang, Haifeng, Mingxia Ding, Ruping Yan, et al.. (2016). LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity. Oncology Letters. 13(2). 661–668. 21 indexed citations
13.
Ding, Mingxia, et al.. (2016). Progesterone and nifedipine for maintenance tocolysis after arrested preterm labor: A systematic review and meta-analysis of randomized controlled trial. Taiwanese Journal of Obstetrics and Gynecology. 55(3). 399–404. 12 indexed citations
14.
Li, Chong, Ying Du, Zhao Yang, et al.. (2015). GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-Renewal and Tumor-Initiating Capacity of Bladder Cancer Stem Cells. Cancer Research. 76(5). 1273–1283. 68 indexed citations
15.
Ding, Mingxia, Xiaogang Li, & Tian Qiu. (2015). Combination of multiple gene markers to detect circulating tumor cells in the peripheral blood of patients with non-small cell lung cancer using real-time PCR. Genetics and Molecular Research. 14(4). 13033–13040. 4 indexed citations
16.
Zhu, Gui-fang, Zhimeng Fan, Mingxia Ding, et al.. (2015). An EGFR/PI3K/AKT axis promotes accumulation of the Rac1-GEF Tiam1 that is critical in EGFR-driven tumorigenesis. Oncogene. 34(49). 5971–5982. 70 indexed citations
17.
Wang, Chunhui, Jiansong Wang, Hui Zhan, et al.. (2013). Apoptin induces apoptosis in nude mice allograft model of human bladder cancer by altering multiple bladder tumor-associated gene expression profiles. Tumor Biology. 34(3). 1667–1678. 7 indexed citations
18.
Zhan, Hui, et al.. (2012). Apoptin Induces Apoptosis in Human Bladder Cancer EJ and BIU-87 Cells. Asian Pacific Journal of Cancer Prevention. 13(1). 135–138. 2 indexed citations
19.
Ding, Mingxia, Jiansong Wang, Hui Zhan, et al.. (2012). ppGalNAc T1 as a Potential Novel Marker for Human Bladder Cancer. Asian Pacific Journal of Cancer Prevention. 13(11). 5653–5657. 20 indexed citations
20.
Tao, Qing, Haisong Liu, Wei Shen, et al.. (2007). Mature oocytes derived from purified mouse fetal germ cells. Human Reproduction. 23(1). 54–61. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026